Tower Research Capital LLC (TRC) - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is and the CUSIP is 00444T209. A total of 34 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$6,962
-16.4%
7,823
-3.3%
0.00%
Q1 2024$8,330
+48.6%
8,087
+6.0%
0.00%
Q4 2023$5,606
+23.8%
7,627
-2.4%
0.00%
Q3 2023$4,530
-42.5%
7,811
+10.0%
0.00%
Q2 2023$7,880
+112471.4%
7,099
-36.5%
0.00%
Q1 2023$7
-22.2%
11,181
+189.1%
0.00%
Q4 2022$93,8670.00%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
CANTOR FITZGERALD, L. P. 712,050$3,488,4810.72%
Rosalind Advisors, Inc. 758,966$557,8400.46%
Values First Advisors, Inc. 135,238$99,4000.06%
Nantahala Capital Management 2,475,038$1,819,1520.05%
Nantahala Capital Management 1,510,000$1,109,8500.03%
TANG CAPITAL MANAGEMENT LLC 195,000$143,3250.01%
Rock Springs Capital Management LP 316,460$232,5980.01%
Turtle Creek Wealth Advisors, LLC 23,500$17,2730.01%
Virtu Financial LLC 65,667$480.00%
WELLS FARGO & COMPANY/MN 901$6630.00%
View complete list of ACELRX PHARMACEUTICALS INC shareholders